Low-risk AND rapid? Brit vaccine centre seeks ERP to meet accelerated schedule, and needs it yesterday

Org was originally supposed to launch in 2022 – then a pandemic happened


The UK's £158m Vaccines Manufacturing Innovation Centre (VMIC) has an "urgent requirement" for a £7m SaaS ERP system as the facility's launch is being accelerated due to the ongoing COVID-19 pandemic.

The government-backed organisation designed to work across universities and industry was first announced in 2018 before the coronavirus outbreak.

Originally planned top open before the end of 2022, the launch was brought forward to 2021 in response to the pandemic.

A tender notice from the VMIC, a UK nonprofit, said the ERP must be locally hosted, with the contract worth up to £7m set to include consultation, project management, implementation, hosting, service support and upgrades, and disaster recovery. It will need to support a regulated pharmaceutical environment such as industry-standard GxP compliance requirements including EudraLex Volume 4, for example.

The tender says the organisation has come to the point where it needs an ERP system, and the need is pressing.

"Given the prevailing circumstances, VMIC must make every effort to bring online its manufacturing and support services at the earliest opportunity. To meet this goal the implementation of an ERP system is considered an urgent requirement," the contract notice said.

"VMIC recognises that the service provider will be required to speedily provide robust solutions to its specific industry needs and anticipates a fully-managed configured off-the-shelf solution delivered with extensive support services based on industry knowledge and expertise, best in class project management and a low-risk rapid implementation."

The organisation expects to buy 30 concurrent and 60 named user licences. The initial contract will be for three years, with the option to extend twice by two years on each occasion. The estimated £7m cost covers the entire period.

VMIC was established by the University of Oxford, Imperial College, and London School of Hygiene and Tropical Medicine with support from industrial partners MSD, Johnson & Johnson, and Cytiva, formerly known as GE Healthcare. Initial funding came from a £65m grant from UK Research and Innovation; in 2020 it received an extra £93m to expand the facility's capabilities and fast track the build.

Despite the accelerated timetable, for Sarah Gilbert, professor of vaccinology at the University of Oxford, it has not been quick enough. The researcher who led the development of the UK's celebrated Oxford vaccine told The Guardian: "It is wonderful that we are getting the centre, but it won't be ready until late 2021. It would have been better if it had been up and running in 2020. It is going to help us in the future, but there wasn't sufficient emphasis on getting it ready quickly."

Experienced professionals for whom saying "low-risk rapid implementation" and "ERP" in the same sentence is difficult might worry that the current timetable is vulnerable to slippage. ®

Broader topics

Narrower topics


Other stories you might like

  • Cheers ransomware hits VMware ESXi systems
    Now we can say extortionware has jumped the shark

    Another ransomware strain is targeting VMware ESXi servers, which have been the focus of extortionists and other miscreants in recent months.

    ESXi, a bare-metal hypervisor used by a broad range of organizations throughout the world, has become the target of such ransomware families as LockBit, Hive, and RansomEXX. The ubiquitous use of the technology, and the size of some companies that use it has made it an efficient way for crooks to infect large numbers of virtualized systems and connected devices and equipment, according to researchers with Trend Micro.

    "ESXi is widely used in enterprise settings for server virtualization," Trend Micro noted in a write-up this week. "It is therefore a popular target for ransomware attacks … Compromising ESXi servers has been a scheme used by some notorious cybercriminal groups because it is a means to swiftly spread the ransomware to many devices."

    Continue reading
  • Twitter founder Dorsey beats hasty retweet from the board
    As shareholders sue the social network amid Elon Musk's takeover scramble

    Twitter has officially entered the post-Dorsey age: its founder and two-time CEO's board term expired Wednesday, marking the first time the social media company hasn't had him around in some capacity.

    Jack Dorsey announced his resignation as Twitter chief exec in November 2021, and passed the baton to Parag Agrawal while remaining on the board. Now that board term has ended, and Dorsey has stepped down as expected. Agrawal has taken Dorsey's board seat; Salesforce co-CEO Bret Taylor has assumed the role of Twitter's board chair. 

    In his resignation announcement, Dorsey – who co-founded and is CEO of Block (formerly Square) – said having founders leading the companies they created can be severely limiting for an organization and can serve as a single point of failure. "I believe it's critical a company can stand on its own, free of its founder's influence or direction," Dorsey said. He didn't respond to a request for further comment today. 

    Continue reading
  • Snowflake stock drops as some top customers cut usage
    You might say its valuation is melting away

    IPO darling Snowflake's share price took a beating in an already bearish market for tech stocks after filing weaker than expected financial guidance amid a slowdown in orders from some of its largest customers.

    For its first quarter of fiscal 2023, ended April 30, Snowflake's revenue grew 85 percent year-on-year to $422.4 million. The company made an operating loss of $188.8 million, albeit down from $205.6 million a year ago.

    Although surpassing revenue expectations, the cloud-based data warehousing business saw its valuation tumble 16 percent in extended trading on Wednesday. Its stock price dived from $133 apiece to $117 in after-hours trading, and today is cruising back at $127. That stumble arrived amid a general tech stock sell-off some observers said was overdue.

    Continue reading

Biting the hand that feeds IT © 1998–2022